The Thyroid Eye Disease market report provides in-depth current treatment practices, emerging drugs, Thyroid Eye Disease market share of the individual therapies, current and forecasted Thyroid Eye Disease market Size from 2017 to 2030 segmented by seven major markets.
The report also provides comprehensive current Thyroid Eye Disease treatment practice & algorithm, market drivers, market barriers and unmet medical needs to cater best of the opportunities and assessments underlying potential of Thyroid Eye Disease market.
Thyroid Eye Disease market key facts
A higher prevalence of Thyroid Eye Disease has been observed in women as compared to men (16 per 100,000 vs. 3 per 100,000, respectively).
Both men and women demonstrate a bimodal pattern of age of diagnosis for Thyroid Eye Disease (i.e 40–44 and 60–64 years in women; 45–49 and 65–69 years in men).
According to a review article titled “Epidemiology and Prevention of Graves’ Ophthalmopathy” by Wilmar et al., Graves’ ophthalmopathy is clinically relevant in approximately 50% of patients with Graves’ disease, and severe forms affect less than 5% of patients.
Request for Sample Pages: https://www.delveinsight.com/report-store/thyroid-eye-disease-market
Key benefits of Thyroid Eye Disease Market report
Thyroid Eye Disease market report provides an in-depth analysis of Thyroid Eye Disease market, size, share, trend analysis epidemiology and market forecast till 2030, in 7 major market i.e. EU5 (Germany, italy, Spain, France and the UK), Japan, and the United States.
The Thyroid Eye Disease market report covers Thyroid Eye Disease current treatment practices, emerging drugs, market share of the individual therapies.
The Thyroid Eye Disease market report covers the marketed and emerging therapies of Thyroid Eye Disease .
The Thyroid Eye Disease market report helps businesses understand the Thyroid Eye Disease market trends that will shape and drive the Thyroid Eye Disease market in upcoming years.
The Thyroid Eye Disease market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Thyroid Eye Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
Thyroid Eye Disease market segment gives a thorough detail of Thyroid Eye Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
The Thyroid Eye Disease epidemiology division provides insights about historical and current Thyroid Eye Disease patient pool and forecasted trends for every seven major countries.
The disease epidemiology covered in the report provides historical as well as forecasted Thyroid Eye Disease epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
The epidemiology segment also provides the Thyroid Eye Disease epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan along with diagnosed patient pools and their trends with assumptions undertaken.
The launch of the emerging therapies is expected to significantly impact the Thyroid Eye Disease treatment scenario in the upcoming years. Some of the drugs covered in the report include RVT‐1401, Teprotumumab and many others. The key players in the Thyroid Eye Disease market include Immunovant Sciences, Horizon Therapeutics, and many others.
Table of contents
1. Key Insights
2. Executive Summary of Thyroid Eye Disease
3. Thyroid Eye Disease Competitive Intelligence Analysis
4. Thyroid Eye Disease Market Overview at a Glance
5. Thyroid Eye Disease Disease Background and Overview
6. Thyroid Eye Disease Patient Journey
7. Thyroid Eye Disease Epidemiology and Patient Population
8. Thyroid Eye Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Thyroid Eye Disease Unmet Needs
10. Key Endpoints of Thyroid Eye Disease Treatment
11. Thyroid Eye Disease Marketed Products
12. Thyroid Eye Disease Emerging Therapies
13. Thyroid Eye Disease Seven Major Market Analysis
14. Attribute analysis
15. Thyroid Eye Disease Market Outlook (in 7 major markets)
16. Access and Reimbursement Overview of Thyroid Eye Disease
17. KOL Views on the Thyroid Eye Disease market.
18. Thyroid Eye Disease Market Drivers
19. Thyroid Eye Disease Market Barriers
21. DelveInsight Capabilities
23. About DelveInsight
DelveInsight’s ‘Thyroid Eye Disease Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Thyroid Eye Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
“Thyroid Eye Disease Pipeline Insight, 2020” report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Thyroid Eye Disease market. A detailed picture of the Thyroid Eye Disease pipeline landscape is provided, which includes the disease overview and Thyroid Eye Disease treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States